Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505)
Shanghai Stock Exchange · China · prices in CNY · close of 19 Oct 2026
Key indicators
| Last close | CNY 7.270 |
|---|---|
| 52-week range | 6.580 – 9.500 |
| Return, 1 month / 3 months | −5.0% / −8.9% |
| Return, 1 year / 3 years | −20.5% / −23.8% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 32.3% |
| Worst drawdown (1 year) | -28.7% |
| Average daily value traded | 78.29M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) trades on the Shanghai Stock Exchange in China. It last closed at CNY 7.270 on 19 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 576 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.5% and over the last three months it fell 8.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -8.7% | ||
| From 52-week high | -22.4% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.9% | ||
| 6-month return | -7.9% | ||
| 12-month return, skipping the last month | -16.3% | ||
| Risk (lower is better) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 32.3% | ||
| Worst drawdown (1 year) | -28.7% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 78.29M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −10.9% |
|---|---|
| 1 month | −5.0% |
| 3 months | −8.9% |
| 6 months | −7.9% |
| 1 year | −20.5% |
| 3 years | −23.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 8.049 / 7.967 |
|---|---|
| Golden / death cross (60 days) | Golden, 6 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.353 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Jul 2025 | CNY 0.0300 |
| 30 Aug 2024 | CNY 0.0200 |
| 12 Jul 2024 | CNY 0.0700 |
| 7 Jul 2023 | CNY 0.0700 |
| 20 Jul 2022 | CNY 0.0700 |
| 23 Jun 2021 | CNY 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.